Program
Preliminary PROGRAM

Download the Preliminary Program (PDF, 648 KB)
Updated Thursday 2 March; 11:00 EST
Program is subject to change.
All times are Eastern Time.
Tuesday 25 aPRIL
7:15 - 8:30 |
Co-developed learning activities
|
9:00 - 10:30 |
Opening Plenary: Applying pandemic learnings to routine immunization programs |
10:30 - 11:15 |
Refreshment break with Sponsors and Exhibitors |
11:15 - 12:45 |
Concurrent Sessions
- Economic evidence for national and provincial/ territorial vaccine decision-making in Canada
- Ensuring immunization of structurally-disadvantaged populations – Black People and other people of colour
- Mind The Gap! Filling the space between misinformation and the different types of vaccine hesitancy
- New vaccine landscapes: Regulation of new platforms, immunization routes, and vaccine strategies for respiratory viruses
- Oral presentations
|
12:45 - 13:45
|
Networking Lunch
|
13:50 - 14:50 |
Poster Presentations |
15:00 - 16:30 |
Concurrent Sessions
- Enhancing knowledge in immunity and immunization through modelling
- Exploring peoples-specific and community-specific facilitators and barriers to HPV immunization uptake in First Nations, Inuit, Métis, and urban Indigenous communities
- Improving vaccination discussions and uptake in pregnancy: The value of applying implementation science to improve clinical practices
- Mpox vaccine response in Canada: Emergency response necessitating interplay between multiple levels of public health
- Oral presentations
|
17:00 - 18:30 |
Co-developed learning activity
|
Wednesday 26 aPRIL
7:15 - 8:30 |
Co-developed learning activities
|
9:00 - 10:30 |
Plenary II: Unlearning and undoing systemic white supremacy and Indigenous-specific racism in Public Health |
10:30 - 11:15 |
Refreshment break with Sponsors and Exhibitors |
11:15 - 12:45 |
Concurrent Sessions
- COVID-19 vaccine decision-making, accessibility and information challenges for structurally-disadvantaged populations
- Expanding the types of vaccine providers as a means of expanding capacity during the COVID-19 pandemic: An innovative solution or a risky provisional measure?
- RSV vaccine development
- Sero-epidemiology of vaccine preventable diseases in Canada: Blood operators in action
- Oral presentations
|
12:45 - 13:45
|
Networking Lunch
|
13:50 - 14:50 |
Poster Presentations |
15:00 - 16:30 |
Concurrent Sessions
- Behavioural insights into vaccination: Theories and methods for understanding and increasing uptake
- Mining for silver linings: Exploring learnings and innovations from our mass-immunization efforts during the COVID-19 pandemic response
- Monitoring the safety of vaccination during pregnancy in Canada: Where do we need to go from here?
- Opportunities and challenges for National Immunization Technical Advisory Groups through the COVID-19 pandemic
- Oral presentations
|
17:00 - 18:30 |
Co-developed learning activity
|
thursday 27 aPRIL
7:15 - 8:30 |
Co-developed learning activities
|
9:00 - 10:00 |
Plenary III: A new era of adult immunization |
10:00 - 10:30 |
Refreshment break |
10:30 - 12:00 |
Concurrent Sessions
- 2021 Immunization communication tool for health care providers
- Addressing the needs of immunocomprised populations
- The Immunization Partnership Fund: A spotlight on community-led vaccine confidence initiatives for structurally-disadvantaged populations
- What's new with NACI
- Oral presentations
|
12:00 - 12:30
|
Lunch
|
12:30 - 14:00 |
Plenary IV & Closing: Preventing and preparing for the re-emergence of vaccine-preventable diseases |